Literature DB >> 25596296

Amyloidosis of the renal pelvis: a harbinger of mammary carcinoma?

Thomas Grigor1, Nicolas Munro2.   

Abstract

We describe a rare case of light chain immunoglobulin amyloid (AL) accumulation in the central and lower pole renal calyces. Our patient, a woman aged 60, presented with several episodes of gross haematuria. Radiological imaging detected a filling defect in the left renal pelvis. Rigid ureteroscopy showed a corresponding mucosal abnormality resembling transitional cell carcinoma. A definitive preoperative tissue diagnosis could not be reached. Laparoscopic-assisted left nephroureterectomy was indicated. Histopathological examination excluded malignancy, revealing congophilic deposits of submucosal amyloid. A constellation of findings confirmed localised or primary amyloidosis with an AL immunophenotype but no evidence of clonal B-cell disease in the amyloid-associated lymphoplasmacytic cell infiltrate. Investigation for systemic plasma cell dyscrasia and echocardiography and scintigraphy for visceral amyloid deposits were negative for systemic disease. At a follow-up period of 30 months, there is no recurrence. However, our patient was diagnosed with breast cancer 21 months ago. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25596296      PMCID: PMC4307064          DOI: 10.1136/bcr-2014-207955

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  38 in total

1.  "Primary" systemic amyloidosis and myeloma. Discussion of relationship and review of 81 cases.

Authors:  R A KYLE; E D BAYRD
Journal:  Arch Intern Med       Date:  1961-03

2.  Amyloidosis in association with neoplastic disease. Report of an unusual case and clinicopathological experience at Memorial Center for Cancer and Allied Diseases during eleven years (1948-1958).

Authors:  K G KIMBALL
Journal:  Ann Intern Med       Date:  1961-12       Impact factor: 25.391

Review 3.  Kinetics and thermodynamics of amyloid fibril assembly.

Authors:  Ronald Wetzel
Journal:  Acc Chem Res       Date:  2006-09       Impact factor: 22.384

Review 4.  Localized amyloidosis of the genitourinary tract: report of 5 new cases and review of the literature.

Authors:  Matthieu Monge; Dominique Chauveau; Carole Cordonnier; Laure-Hélène Noël; Claire Presne; Raïfah Makdassi; Maïté Jauréguy; Caroline Lecaque; Marianne Renou; Jean-Pierre Grünfeld; Gabriel Choukroun
Journal:  Medicine (Baltimore)       Date:  2011-05       Impact factor: 1.889

5.  Localized amyloidosis and gastrointestinal lymphoma: a rare association.

Authors:  G Goteri; R Ranaldi; S A Pileri; I Bearzi
Journal:  Histopathology       Date:  1998-04       Impact factor: 5.087

6.  Primary amyloidosis of the renal pelvis.

Authors:  K D Gardner; R A Castellino; R Kempson; B W Young; T A Stamey
Journal:  N Engl J Med       Date:  1971-05-27       Impact factor: 91.245

7.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Authors:  R A Kyle; M A Gertz
Journal:  Semin Hematol       Date:  1995-01       Impact factor: 3.851

Review 8.  Primary localized amyloidosis of the renal pelvis coexisting with transitional cell carcinoma: a case report.

Authors:  M Shiramizu; K Nakamura; S Baba; Y Katsuoka; H Kinoshita
Journal:  Hinyokika Kiyo       Date:  1992-06

9.  Concomitant amyloidosis, renal papillary carcinoma and ipsilateral pelvicalyceal urothelial carcinoma in a patient with familial Mediterranean fever.

Authors:  Alper Kirkpantur; Dilek Ertoy Baydar; Bulent Altun; Musturay Karcaaltincaba; Tuncay Aki; Serdar Yuksel; Cetin Turgan
Journal:  Amyloid       Date:  2009-03       Impact factor: 7.141

Review 10.  Amyloidosis (AL). Clinical and laboratory features in 229 cases.

Authors:  R A Kyle; P R Greipp
Journal:  Mayo Clin Proc       Date:  1983-10       Impact factor: 7.616

View more
  1 in total

1.  Primary localized amyloidoma of the renal pelvis: A case report and literature review.

Authors:  Wei Lu; Yanjun Wang; Meng Zhang; Yonghong Li; Yun Cao; Yongbo Xiao; Zhiming Cai; Song Wu; Fangjian Zhou
Journal:  Oncol Lett       Date:  2015-12-16       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.